Cargando…
Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470607/ http://dx.doi.org/10.1186/cc14431 |
_version_ | 1782376788557561856 |
---|---|
author | Honickel, M Braunschweig, T Ryn, J Van Rossaint, R Grottke, O |
author_facet | Honickel, M Braunschweig, T Ryn, J Van Rossaint, R Grottke, O |
author_sort | Honickel, M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4470607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44706072015-06-29 Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model Honickel, M Braunschweig, T Ryn, J Van Rossaint, R Grottke, O Crit Care Poster Presentation BioMed Central 2015 2015-03-16 /pmc/articles/PMC4470607/ http://dx.doi.org/10.1186/cc14431 Text en Copyright © 2015 Honickel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Honickel, M Braunschweig, T Ryn, J Van Rossaint, R Grottke, O Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model |
title | Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model |
title_full | Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model |
title_fullStr | Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model |
title_full_unstemmed | Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model |
title_short | Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model |
title_sort | efficacy of idarucizumab, prothrombin complex concentrate (pcc) and activated pcc to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470607/ http://dx.doi.org/10.1186/cc14431 |
work_keys_str_mv | AT honickelm efficacyofidarucizumabprothrombincomplexconcentratepccandactivatedpcctoreversetheanticoagulatorypotentialofdabigatraninaporcinepolytraumamodel AT braunschweigt efficacyofidarucizumabprothrombincomplexconcentratepccandactivatedpcctoreversetheanticoagulatorypotentialofdabigatraninaporcinepolytraumamodel AT rynjvan efficacyofidarucizumabprothrombincomplexconcentratepccandactivatedpcctoreversetheanticoagulatorypotentialofdabigatraninaporcinepolytraumamodel AT rossaintr efficacyofidarucizumabprothrombincomplexconcentratepccandactivatedpcctoreversetheanticoagulatorypotentialofdabigatraninaporcinepolytraumamodel AT grottkeo efficacyofidarucizumabprothrombincomplexconcentratepccandactivatedpcctoreversetheanticoagulatorypotentialofdabigatraninaporcinepolytraumamodel |